Glucose-lowering therapy
Glucose-lowering therapy has been studied in 4 papers since 2017: 1 trial and 1 observational study in people, 2 reviews; 3 in the past year. The newest paper, Oct 26, 2026: “Predictors of incident heart failure in people with and without type 2 diabetes free from baseline cardiovascular disease: a UK Biobank study”.
4 papers study itUpdated
1 new paper in 30 daysSee all 4 papers on glucose-lowering therapy
- Human trial1
- Humans1
Latest
3 papers in 12 monthsESC Congress 2026 Abstract
Predictors of incident heart failure in people with and without type 2 diabetes free from baseline cardiovascular disease: a UK Biobank study
Cohort study of 443,244 peopleHeart failure
SOUTH ARAL SEA MEDICAL JOURNAL
DYNAMICS OF MYOKINE STATUS AND METABOLIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SARCOPENIA RECEIVING COMPREHENSIVE THERAPY
Non-randomized trial in 55 peopleSarcopenia
Clinical Interventions in Aging
Frailty-Informed Deprescribing of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: A Pragmatic Clinical Framework
Systematic review of studies in peopleDiabetes mellitus